{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:07:20Z","timestamp":1793444840474,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1124\/dmd.113.052415","type":"journal-article","created":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T04:41:17Z","timestamp":1375504877000},"page":"1835-1842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures"],"prefix":"10.1016","volume":"41","author":[{"given":"C\u00e9line","family":"Parmentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine L.","family":"Truisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Moenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Stanzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kopp-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.052415_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tiv.2009.05.021","article-title":"Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions","volume":"24","author":"Abadie-Viollon","year":"2010","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.113.052415_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3181\/00379727-155-39833","article-title":"Adverse effects of chlorpromazine metabolites on isolated hepatocytes","volume":"155","author":"Abernathy","year":"1977","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/dmd.113.052415_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0887-2333(02)00118-2","article-title":"Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME","volume":"17","author":"Binda","year":"2003","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.113.052415_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498250400021820","article-title":"Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes","volume":"35","author":"Blanchard","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.052415_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00117862","article-title":"Relative cytotoxicity of psychotropic drugs in cultured rat hepatocytes","volume":"3","author":"Boelsterli","year":"1987","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.113.052415_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/toxsci\/kfg064","article-title":"Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems","volume":"73","author":"Boess","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.113.052415_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1124\/dmd.113.052415_bib8","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1016\/j.jchromb.2011.10.020","article-title":"Chlorpromazine quantification in human plasma by UPLC-electrospray ionization tandem mass spectrometry. Application to a comparative pharmacokinetic study","volume":"879","author":"Borges","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.113.052415_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.mpmed.2006.10.005","article-title":"Drugs that damage the liver","volume":"35","author":"Brind","year":"2007","journal-title":"Medicine"},{"key":"10.1124\/dmd.113.052415_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.300.2.460","article-title":"Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?","volume":"300","author":"Buchweitz","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.052415_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00196109","article-title":"Smoking and body weight influence the clearance of chlorpromazine","volume":"46","author":"Chetty","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population based case-control study","volume":"58","author":"de Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2011.05.002","article-title":"Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes","volume":"43","author":"De Bruyn","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.113.052415_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.21160","article-title":"Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation","volume":"43","author":"Demeilliers","year":"2006","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052415_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/00498254.2010.530700","article-title":"Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance","volume":"41","author":"Foster","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.052415_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.113.052415_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-60761-688-7_21","article-title":"The use of hepatocytes to investigate drug toxicity","volume":"640","author":"G\u00f3mez-Lech\u00f3n","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.113.052415_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2008.04.024","article-title":"Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures","volume":"231","author":"Goyak","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.113.052415_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","volume":"196","author":"Hinson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","article-title":"Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans","volume":"18","author":"Horikawa","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.113.052415_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00042737-200411000-00001","article-title":"Non-alcoholic steatohepatitis","volume":"16","author":"Jansen","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1124\/dmd.113.052415_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/dmd.113.052415_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","article-title":"Genetic predisposition to drug-induced hepatotoxicity","volume":"26","author":"Larrey","year":"1997","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.113.052415_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cbi.2008.10.031","article-title":"Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes","volume":"179","author":"Lauer","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.113.052415_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-688-7_3","article-title":"Isolation and culture of primary hepatocytes from resected human liver tissue","volume":"640","author":"Lecluyse","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.113.052415_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2000-9390","article-title":"Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders","volume":"20","author":"Lee","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1124\/dmd.113.052415_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.113.052415_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cbi.2008.09.026","article-title":"Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1","volume":"179","author":"Li","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.113.052415_bib30","doi-asserted-by":"crossref","first-page":"28411","DOI":"10.1074\/jbc.M202807200","article-title":"STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.052415_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hep.20514","article-title":"Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin","volume":"41","author":"Liguori","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052415_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.1998.00662.x","article-title":"Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans","volume":"113","author":"Louis","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/dmd.113.052415_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052415_bib34","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052415_bib35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ejps.2012.01.014","article-title":"Biotransformation of diclofenac and effects on the metabolome of primary human hepatocytes upon repeated dose exposure","volume":"45","author":"Mueller","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.113.052415_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/clpt.1982.72","article-title":"Cigarette smoking and chlorpromazine disposition and actions","volume":"31","author":"Pantuck","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.052415_bib37","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/jm7015683","article-title":"Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)","volume":"51","author":"Pedersen","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.113.052415_bib38","first-page":"787","article-title":"Phenothiazine-induced cholestatic jaundice","volume":"6","author":"Regal","year":"1987","journal-title":"Clin Pharm"},{"key":"10.1124\/dmd.113.052415_bib39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1478-3231.2004.0930.x","article-title":"Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study","volume":"24","author":"Richert","year":"2004","journal-title":"Liver Int"},{"key":"10.1124\/dmd.113.052415_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0887-2333(01)00099-6","article-title":"Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes","volume":"16","author":"Richert","year":"2002","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.113.052415_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0041-008X(03)00231-X","article-title":"Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes","volume":"191","author":"Richert","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib42","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/dmd.105.007708","article-title":"Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating","volume":"34","author":"Richert","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052415_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2008.11.019","article-title":"Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes","volume":"235","author":"Richert","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/dmd.107.018358","article-title":"Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) in vivo and in vitro","volume":"36","author":"Richert","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052415_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/dmd.111.042028","article-title":"Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells","volume":"40","author":"Rogue","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052415_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.041624","article-title":"Inflammation and drug idiosyncrasy\u2014is there a connection?","volume":"307","author":"Roth","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.052415_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cbi.2006.11.002","article-title":"The pivotal role of hepatocytes in drug discovery","volume":"168","author":"Soars","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.113.052415_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)32167-1","article-title":"Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver","volume":"214","author":"Tavoloni","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.052415_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0006-2952(83)90633-0","article-title":"Effect of chlorpromazine on hepatic transport of indocyanine green in rats","volume":"32","author":"Tsao","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cbi.2009.05.015","article-title":"Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies","volume":"181","author":"Tuschl","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.113.052415_bib51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/17425255.4.7.855","article-title":"Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism","volume":"4","author":"Tuschl","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.113.052415_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/alcalc\/agg099","article-title":"Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate","volume":"38","author":"van Pelt","year":"2003","journal-title":"Alcohol Alcohol"},{"key":"10.1124\/dmd.113.052415_bib53","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.bcp.2010.06.045","article-title":"Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver\u2014A comparison with other phenothiazines","volume":"80","author":"W\u00f3jcikowski","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00315316","article-title":"Pharmacokinetics of chlorpromazine and key metabolites","volume":"45","author":"Yeung","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.113.052415_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0024-3205(00)00613-5","article-title":"Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes","volume":"67","author":"Yoshii","year":"2000","journal-title":"Life Sci"},{"key":"10.1124\/dmd.113.052415_bib56","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.biomaterials.2010.09.064","article-title":"A robust high-throughput sandwich cell-based drug screening platform","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1124\/dmd.113.052415_bib57","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/dmd.104.002832","article-title":"Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes","volume":"33","author":"Zhao","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052415_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.052415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:13:54Z","timestamp":1739906034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624098775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090955624098775"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.052415","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.052415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}